Surveillance of SARS-CoV-2 and nosocomial infections causing agents in healthcare settings

SARS-CoV-2 has affected millions of people around the world and resulted in millions of hospitalizations, where it represents a potential source of nosocomial infections for medical staff and patients and the spread of the virus. This study focused on the detection of SARSCoV-2 as well as Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus in healthcare settings, including intensive care units, pediatric intensive care units, and COVID-19 care units. The results showed that SARS-CoV-2 was present in surface samples from the COVID-19 care unit, which detected the presence of the Delta variant. Furthermore, results showed the presence of Pseudomonas aeruginosa and Staphylococcus aureus on hospital surfaces. The presence of SARS-CoV-2 and nosocomial bacteria highlights the importance of constant microbiological monitoring to prevent co-infections and the occurrence of nosocomial infections during hospitalization.